Literature DB >> 35592938

Potential of propolis antifungal activity for clinical applications.

Patrícia Cerqueira1, Ana Cunha1,2,3, Cristina Almeida-Aguiar1,2,3.   

Abstract

The high incidence of skin diseases of microbial origin along with the widespread increase of microbial resistance demand for therapeutic alternatives. Research on natural compounds has been opening new perspectives for the development of new therapies with health-positive impacts. Propolis, a resinous mixture produced by honeybees from plant exudates, is widely used as a natural medicine since ancient times, mainly due to its antimicrobial properties. More recently, antioxidant, anti-tumour, anti-inflammatory, hepatoprotective and immunomodulatory activities were also reported for this natural product, highlighting its high potential pharmacological interest. In the present work, an extensive review of the main fungi causing skin diseases as well as the effects of natural compounds, particularly propolis, against such disease-causing micro-organisms was organized and compiled in concise handy tables. This information allows to conclude that propolis is a highly effective antimicrobial agent suggesting that it could be used as an alternative skin treatment against pathogenic micro-organisms and also as a cosmeceutical component or as a source of bioactive ingredients.
© 2022 Society for Applied Microbiology.

Entities:  

Keywords:  antifungal; bioactivities; dermatophytes; propolis; skin diseases; yeast

Mesh:

Substances:

Year:  2022        PMID: 35592938     DOI: 10.1111/jam.15628

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   4.059


  1 in total

1.  Antifungal Activity of Mexican Propolis on Clinical Isolates of Candida Species.

Authors:  Claudia Rebeca Rivera-Yañez; Porfirio Alonso Ruiz-Hurtado; Julia Reyes-Reali; María Isabel Mendoza-Ramos; María Elena Vargas-Díaz; Karla Mariela Hernández-Sánchez; Glustein Pozo-Molina; Claudia Fabiola Méndez-Catalá; Gina Stella García-Romo; Alexander Pedroza-González; Adolfo René Méndez-Cruz; Oscar Nieto-Yañez; Nelly Rivera-Yañez
Journal:  Molecules       Date:  2022-09-01       Impact factor: 4.927

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.